XML 86 R99.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Segments and Geographic Information - Segment Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 27, 2014 | Jun. 28, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Sep. 28, 2013 | Jun. 29, 2013 | Mar. 30, 2013 | Dec. 29, 2012 | Sep. 27, 2014 | Sep. 28, 2013 | Sep. 29, 2012
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Total revenues | $ 660,600,000 | $ 632,600,000 | $ 625,000,000 | $ 612,400,000 | $ 622,100,000 | $ 626,100,000 | $ 612,700,000 | $ 631,400,000 | $ 2,530,700,000 | $ 2,492,300,000 | $ 2,002,600,000
Operating income (loss) |  |  |  |  |  |  |  |  | 279,700,000 | (906,200,000) | 113,700,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 523,200,000 | 516,000,000 | 345,800,000
Capital expenditures |  |  |  |  |  |  |  |  | 80,200,000 | 90,100,000 | 78,700,000
Identifiable assets | 8,414,700,000 |  |  |  | 9,000,800,000 |  |  |  | 8,414,700,000 | 9,000,800,000 | 10,477,100,000
Diagnostics [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  | 1,186,800,000 | 1,189,800,000 | 718,100,000
Operating income (loss) |  |  |  |  |  |  |  |  | 48,700,000 | (1,149,100,000) | (32,800,000)
Depreciation and amortization |  |  |  |  |  |  |  |  | 376,000,000 | 369,800,000 | 197,300,000
Capital expenditures |  |  |  |  |  |  |  |  | 52,200,000 | 51,600,000 | 44,900,000
Identifiable assets | 4,383,500,000 |  |  |  | 4,667,900,000 |  |  |  | 4,383,500,000 | 4,667,900,000 | 6,170,500,000
Breast Health [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  | 944,700,000 | 905,100,000 | 875,800,000
Operating income (loss) |  |  |  |  |  |  |  |  | 187,600,000 | 216,100,000 | 186,100,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 41,700,000 | 40,100,000 | 42,900,000
Capital expenditures |  |  |  |  |  |  |  |  | 10,000,000 | 16,400,000 | 9,800,000
Identifiable assets | 859,800,000 |  |  |  | 932,200,000 |  |  |  | 859,800,000 | 932,200,000 | 956,100,000
GYN Surgical [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  | 307,900,000 | 307,100,000 | 313,100,000
Operating income (loss) |  |  |  |  |  |  |  |  | 30,300,000 | 19,700,000 | (51,900,000)
Depreciation and amortization |  |  |  |  |  |  |  |  | 104,600,000 | 105,200,000 | 103,800,000
Capital expenditures |  |  |  |  |  |  |  |  | 8,000,000 | 9,100,000 | 12,200,000
Identifiable assets | 1,748,200,000 |  |  |  | 1,849,500,000 |  |  |  | 1,748,200,000 | 1,849,500,000 | 1,944,400,000
Skeletal Health [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  | 91,300,000 | 90,300,000 | 95,600,000
Operating income (loss) |  |  |  |  |  |  |  |  | 13,100,000 | 7,100,000 | 12,300,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 900,000 | 900,000 | 1,800,000
Capital expenditures |  |  |  |  |  |  |  |  | 400,000 | 600,000 | 200,000
Identifiable assets | 26,100,000 |  |  |  | 33,500,000 |  |  |  | 26,100,000 | 33,500,000 | 32,800,000
Corporate [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Capital expenditures |  |  |  |  |  |  |  |  | 9,600,000 | 12,400,000 | 11,600,000
Identifiable assets | $ 1,397,100,000 |  |  |  | $ 1,517,700,000 |  |  |  | $ 1,397,100,000 | $ 1,517,700,000 | $ 1,373,300,000

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationAmortizationAndAccretionNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration